Nanotechnology researchers have discovered new tools that could change how cancers and brain diseases are treated in the future. [ + ]

The National Biosecurity Committee has agreed that the national release of Rabbit Haemorrhagic Disease Virus (RHDV1) K5 is now likely to take place in Spring 2016 or Autumn 2017. [ + ]

A new class of vitamin-like molecules can be used to treat life-threatening golden staph — a dangerous bacteria that is resistant to many common antibiotics. [ + ]

The British Council is looking for early-career researchers with a peer-reviewed discovery and a flair for communication to present their science at FameLab Australia. [ + ]

Mettler-Toledo will market, sell and service product inspection, industrial weighing and vehicle weighing equipment directly in New Zealand. [ + ]

It's been a busy month for Cynata Therapeutics, with the company signing two letters of intent regarding the licensing and development of its proprietary MSC technology, Cymerus. [ + ]

Imugene has received a Notice of Grant from the European Patent Office for Patent Application 10744895.3, which protects the company's HER-Vaxx cancer immunotherapy. [ + ]

Associate Professor Chamindie Punyadeera is looking to produce a heart failure test that is quick and easy to administer, by screening saliva instead of blood. [ + ]

The Australian Research Council has announced $38.6 million of funding to support 50 new research projects as part of the Future Fellowships initiative. [ + ]

The projected rate of return on pharmaceutical R&D has more than halved since 2010, from 10.1% to 4.2%, according to an annual study by the Deloitte Centre for Health Solutions. [ + ]

Pharmaxis has announced positive results for its recently completed Phase II trial of Bronchitol, a precision spray-dried form of mannitol, in children and adolescents with cystic fibrosis (CF). [ + ]

Researchers have discovered that tissue-resident memory T cells — specialised immune cells that live in tissues such as the skin and lung — play an important role in protecting against infection. [ + ]

GSK Australia's new pilot facility will use an innovative manufacturing method to produce vaccines on a commercial scale. [ + ]

The boards of DuPont and The Dow Chemical Company have unanimously approved a definitive agreement under which the companies will combine in an all-stock merger of equals. [ + ]

A University of Melbourne research team will use a US$200,000 grant from the Bill & Melinda Gates Foundation to develop a one-shot vaccine for Taenia solium. [ + ]